These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 4403455

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
    Meekers J, Missotten A, Fagard R, Demuynck D, Harvengt C, Pas P, Billiet L, Amery A.
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The sixth Volhard Lecture: Causal and homoeostatic factors in hypertension.
    Korner PI.
    Clin Sci (Lond); 1982 Oct; 63 Suppl 8():5S-26S. PubMed ID: 6751653
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hemodynamic alterations in hypertension--spontaneous changes and effects of drug therapy. A review.
    Lund-Johansen P.
    Acta Med Scand Suppl; 1977 Oct; 603():1-14. PubMed ID: 325997
    [No Abstract] [Full Text] [Related]

  • 29. Vasodilation in treatment of hypertension.
    Chidsey CA.
    N Engl J Med; 1970 May 07; 282(19):1102-3. PubMed ID: 4392414
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E, Istvánffy M, Halmágyi M, Wagner M, Csukás M.
    Int J Clin Pharmacol Ther Toxicol; 1980 May 07; 18(5):200-7. PubMed ID: 6104634
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS, March H, Vangrow JS, Cassidy J, Kern JC, Khemka M, Vawter M, Pagano J.
    Br Heart J; 1974 Nov 07; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract] [Full Text] [Related]

  • 35. Hypotensive mechanisms of beta blockers.
    Conway J.
    Eur Heart J; 1983 Jul 07; 4 Suppl D():43-51. PubMed ID: 6137382
    [Abstract] [Full Text] [Related]

  • 36. Hemodynamics of renal arterial diseases and hypertension.
    Frohlich ED, Ulrych M, Tarazi RC, Dustan HP, Page IH.
    Am J Med Sci; 1968 Jan 07; 255():29-37. PubMed ID: 4383912
    [No Abstract] [Full Text] [Related]

  • 37. Plasma volume changes with long-term beta-adrenergic blockade.
    Tarazi RC, Frohlich ED, Dustan HP.
    Am Heart J; 1971 Dec 07; 82(6):770-6. PubMed ID: 4399785
    [No Abstract] [Full Text] [Related]

  • 38. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
    Franciosa JA, Johnson SM, Tobian LJ.
    Chest; 1980 Aug 07; 78(2):291-9. PubMed ID: 6995041
    [No Abstract] [Full Text] [Related]

  • 39. Effect of beta-adrenergic receptor blockade on coronary haemodynamics in the resting unanaesthetized dog.
    Pitt B, Green HL, Sugishita Y.
    Cardiovasc Res; 1970 Jan 07; 4(1):89-92. PubMed ID: 4392025
    [No Abstract] [Full Text] [Related]

  • 40. Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.
    Prichard BN.
    Br J Clin Pharmacol; 1982 Jan 07; 13(1):51-60. PubMed ID: 6121573
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.